Alerts will be sent to your verified email
Verify Email
ORTINGLOBE
|
Ortin Global
|
Beryl Drugs
|
Colinz Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-64.74 % | 3.64 % | 4.71 % |
|
5yr average Equity Multiplier
|
2.06 | 2.12 | 1.29 |
|
5yr Average Asset Turnover Ratio
|
0.28 | 1.19 | 0.64 |
|
5yr Avg Net Profit Margin
|
-124.59 % | 1.13 % | 5.84 % |
|
Price to Book
|
9.24 | 1.27 | 1.21 |
|
P/E
|
0.0 | 50.28 | 25.9 |
|
5yr Avg Cash Conversion Cycle
|
1016.26 Days | -589.78 Days | -11.59 Days |
|
Inventory Days
|
326.59 Days | 36.09 Days | 56.66 Days |
|
Days Receivable
|
1081.4 Days | 112.55 Days | 42.5 Days |
|
Days Payable
|
645.07 Days | 964.25 Days | 89.1 Days |
|
5yr Average Interest Coverage Ratio
|
-64.13 | 1.91 | 11.55 |
|
5yr Avg ROCE
|
-34.49 % | 7.2 % | 6.71 % |
|
5yr Avg Operating Profit Margin
|
-107.87 % | 6.72 % | 7.54 % |
|
5 yr average Debt to Equity
|
0.51 | 0.59 | 0.07 |
|
5yr CAGR Net Profit
|
n/a | 19.3 % | 18.95 % |
|
5yr Average Return on Assets
|
-25.0 % | 1.98 % | 3.68 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
1.23 % | 26.38 % | 66.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-14.45 % | 1.46 % | 0.07 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ortin Global
|
Beryl Drugs
|
Colinz Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|